Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1446 crossover qEEG/ERP study in mild-to-moderate Alzheimer's disease
2010-018273-38Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of azd1446 and donepezil in Alzheimer's disease (AD) (3 arms), sponsored by AstraZeneca. Primary endpoints: Quantitative electroencephalography and Event-related potentials. Started Feb 2010; status: completed.
02
Drugs
azd1446donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2010-018273-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018273-38.